Spermosens AB (publ) INTERIM REPORT JANUARY - JUNE 2024
The revised strategy positions Spermosens optimally to unlock the full potential of its groundbreaking product. Spermosens AB's interim report for the period January - June 2024, is now available on the Company's website and attached to this press release.1 JANUARY – 30 JUNE 2024 SIGNIFICANT EVENTS DURING THE QUARTER · Spermosens receives patent approval in Singapore · The rights issue carried out during the month of April provided the company with SEK 24.2 million before issue costs, which amount to approximately SEK 7.0 million · Spermosens appoints Tore Duvold as new